Vera Therapeutics (VERA) Competitors $21.31 -1.43 (-6.29%) Closing price 04:00 PM EasternExtended Trading$21.32 +0.02 (+0.07%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERA vs. AXSM, BPMC, TLX, KRYS, ELAN, VRNA, NUVL, GRFS, PCVX, and CYTKShould you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include Axsome Therapeutics (AXSM), Blueprint Medicines (BPMC), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Krystal Biotech (KRYS), Elanco Animal Health (ELAN), Verona Pharma (VRNA), Nuvalent (NUVL), Grifols (GRFS), Vaxcyte (PCVX), and Cytokinetics (CYTK). These companies are all part of the "pharmaceutical products" industry. Vera Therapeutics vs. Axsome Therapeutics Blueprint Medicines Telix Pharmaceuticals Limited American Depositary Shares Krystal Biotech Elanco Animal Health Verona Pharma Nuvalent Grifols Vaxcyte Cytokinetics Vera Therapeutics (NASDAQ:VERA) and Axsome Therapeutics (NASDAQ:AXSM) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Do analysts recommend VERA or AXSM? Vera Therapeutics presently has a consensus target price of $64.67, indicating a potential upside of 203.46%. Axsome Therapeutics has a consensus target price of $167.64, indicating a potential upside of 69.58%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Vera Therapeutics is more favorable than Axsome Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 3 Strong Buy rating(s) 3.20Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, VERA or AXSM? Vera Therapeutics has higher earnings, but lower revenue than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Vera Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$95.99M-$2.75-7.75Axsome Therapeutics$385.69M12.50-$287.22M-$5.99-16.50 Which has more risk and volatility, VERA or AXSM? Vera Therapeutics has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Axsome Therapeutics has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Does the media refer more to VERA or AXSM? In the previous week, Axsome Therapeutics had 17 more articles in the media than Vera Therapeutics. MarketBeat recorded 26 mentions for Axsome Therapeutics and 9 mentions for Vera Therapeutics. Vera Therapeutics' average media sentiment score of 0.81 beat Axsome Therapeutics' score of 0.31 indicating that Vera Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Axsome Therapeutics 7 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 5 Negative mention(s) 2 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in VERA or AXSM? 99.2% of Vera Therapeutics shares are held by institutional investors. Comparatively, 81.5% of Axsome Therapeutics shares are held by institutional investors. 21.7% of Vera Therapeutics shares are held by insiders. Comparatively, 22.4% of Axsome Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is VERA or AXSM more profitable? Vera Therapeutics has a net margin of 0.00% compared to Axsome Therapeutics' net margin of -74.47%. Vera Therapeutics' return on equity of -50.13% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -50.13% -39.50% Axsome Therapeutics -74.47%-223.51%-39.88% Does the MarketBeat Community believe in VERA or AXSM? Axsome Therapeutics received 437 more outperform votes than Vera Therapeutics when rated by MarketBeat users. Likewise, 70.50% of users gave Axsome Therapeutics an outperform vote while only 66.13% of users gave Vera Therapeutics an outperform vote. CompanyUnderperformOutperformVera TherapeuticsOutperform Votes4166.13% Underperform Votes2133.87% Axsome TherapeuticsOutperform Votes47870.50% Underperform Votes20029.50% SummaryVera Therapeutics beats Axsome Therapeutics on 12 of the 18 factors compared between the two stocks. Remove Ads Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERA vs. The Competition Export to ExcelMetricVera TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45B$6.72B$5.53B$7.50BDividend YieldN/A2.85%4.87%4.05%P/E Ratio-8.716.9923.1218.08Price / SalesN/A198.60360.0289.38Price / CashN/A65.6738.1634.64Price / Book11.725.926.473.99Net Income-$95.99M$142.37M$3.21B$247.18M7 Day Performance-14.61%-7.24%-4.97%-4.25%1 Month Performance-20.49%-10.45%-0.14%-6.87%1 Year Performance-39.21%-14.58%6.19%-3.73% Vera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERAVera Therapeutics2.8832 of 5 stars$21.31-6.3%$64.67+203.5%-42.6%$1.36BN/A-8.1640News CoverageGap DownAXSMAxsome Therapeutics4.6308 of 5 stars$116.63-1.6%$167.64+43.7%+46.8%$5.69B$385.69M-19.47380Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap DownBPMCBlueprint Medicines2.6463 of 5 stars$88.51-0.2%$124.95+41.2%-5.6%$5.66B$508.82M-81.95640News CoveragePositive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.76-2.8%$22.00+31.3%N/A$5.65B$783.21M0.00N/ANews CoverageGap DownKRYSKrystal Biotech4.7985 of 5 stars$180.30-2.0%$220.00+22.0%+0.1%$5.19B$290.52M60.30210Analyst RevisionNews CoveragePositive NewsGap DownELANElanco Animal Health3.9021 of 5 stars$10.49+0.7%$15.17+44.7%-37.3%$5.19B$4.44B26.219,800Gap DownVRNAVerona Pharma3.1614 of 5 stars$63.49+1.3%$69.14+8.9%+257.9%$5.13B$42.28M-33.0730Gap DownNUVLNuvalent2.223 of 5 stars$70.92-2.9%$113.10+59.5%-7.7%$5.08BN/A-20.4440News CoveragePositive NewsGap DownGRFSGrifols3.6774 of 5 stars$7.11-2.2%N/A+3.2%$4.89B$7.21B6.0826,300Gap DownPCVXVaxcyte2.4993 of 5 stars$37.76-45.6%$147.50+290.6%-53.1%$4.86BN/A-8.21160Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeCYTKCytokinetics3.887 of 5 stars$40.19-6.9%$82.00+104.0%-42.9%$4.76B$18.47M-7.47250Analyst Forecast Remove Ads Related Companies and Tools Related Companies Axsome Therapeutics Competitors Blueprint Medicines Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors Krystal Biotech Competitors Elanco Animal Health Competitors Verona Pharma Competitors Nuvalent Competitors Grifols Competitors Vaxcyte Competitors Cytokinetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
